Alexa P Kaskowitz1, Melina Dendrinos1, Pamela J Murray2, Elisabeth H Quint1, Susan Ernst3. 1. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan. 2. Department of Pediatrics, WVU School of Medicine, Morgantown, West Virginia. 3. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan. Electronic address: sernst@med.umich.edu.
Abstract
STUDY OBJECTIVE: To characterize menstrual health issues and their effect in young women with Angelman syndrome (AS). Our secondary objective was to compare them with young women with autism spectrum disorders (ASDs). DESIGN: Cross-sectional convenience sample survey. SETTING: An institutional review board-approved Web-based survey of young female members of the Angelman Syndrome Foundation. PARTICIPANTS: Caregivers of young women with AS, aged 12-25 years. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Symptom characterization and effect of menses on young women with AS. RESULTS: Menstrual and premenstrual symptoms were common among young women with AS, but infrequently caused problems at home or school. Less than half of the subjects used hormones to control their flow. Of those who used hormones, 75% used them continuously. Caregivers were satisfied with their method to control periods. Girls with seizures were more likely to use hormonal methods to control menses than those without seizures. Menstrual-associated morbidity in young women with ASD and AS was fairly similar, but with greater morbidity in the ASD group than in the AS group. However, girls with AS had more problems with menstrual hygiene with almost all of them requiring full assistance for managing hygiene. CONCLUSION: In this group of young women with AS, who have moderate to severe neurodevelopmental disabilities and cannot manage their own hygiene, menstruation is not associated with significant problems. Menstrual management by hormones is used by less than half. When hormonal therapy is used, it is most commonly used continuously to suppress menses.
STUDY OBJECTIVE: To characterize menstrual health issues and their effect in young women with Angelman syndrome (AS). Our secondary objective was to compare them with young women with autism spectrum disorders (ASDs). DESIGN: Cross-sectional convenience sample survey. SETTING: An institutional review board-approved Web-based survey of young female members of the Angelman Syndrome Foundation. PARTICIPANTS: Caregivers of young women with AS, aged 12-25 years. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Symptom characterization and effect of menses on young women with AS. RESULTS: Menstrual and premenstrual symptoms were common among young women with AS, but infrequently caused problems at home or school. Less than half of the subjects used hormones to control their flow. Of those who used hormones, 75% used them continuously. Caregivers were satisfied with their method to control periods. Girls with seizures were more likely to use hormonal methods to control menses than those without seizures. Menstrual-associated morbidity in young women with ASD and AS was fairly similar, but with greater morbidity in the ASD group than in the AS group. However, girls with AS had more problems with menstrual hygiene with almost all of them requiring full assistance for managing hygiene. CONCLUSION: In this group of young women with AS, who have moderate to severe neurodevelopmental disabilities and cannot manage their own hygiene, menstruation is not associated with significant problems. Menstrual management by hormones is used by less than half. When hormonal therapy is used, it is most commonly used continuously to suppress menses.
Authors: Lori M Burke; Claire Z Kalpakjian; Yolanda R Smith; Elisabeth H Quint Journal: J Pediatr Adolesc Gynecol Date: 2009-07-29 Impact factor: 1.814
Authors: Yolanda A Kirkham; Lisa Allen; Sari Kives; Nicolette Caccia; Rachel F Spitzer; Melanie P Ornstein Journal: J Adolesc Health Date: 2013-06-12 Impact factor: 5.012
Authors: Jessica Duis; Mark Nespeca; Jane Summers; Lynne Bird; Karen G C B Bindels-de Heus; M J Valstar; Marie-Claire Y de Wit; C Navis; Maartje Ten Hooven-Radstaake; Bianca M van Iperen-Kolk; Susan Ernst; Melina Dendrinos; Terry Katz; Gloria Diaz-Medina; Akshat Katyayan; Srishti Nangia; Ronald Thibert; Daniel Glaze; Christopher Keary; Karine Pelc; Nicole Simon; Anjali Sadhwani; Helen Heussler; Anne Wheeler; Caroline Woeber; Margaret DeRamus; Amy Thomas; Emily Kertcher; Lauren DeValk; Kristen Kalemeris; Kara Arps; Carol Baym; Nicole Harris; John P Gorham; Brenda L Bohnsack; Reid C Chambers; Sarah Harris; Henry G Chambers; Katherine Okoniewski; Elizabeth R Jalazo; Allyson Berent; Carlos A Bacino; Charles Williams; Anne Anderson Journal: Mol Genet Genomic Med Date: 2022-02-11 Impact factor: 2.183
Authors: Elia Fernández-Martínez; María Dolores Onieva-Zafra; Ana Abreu-Sánchez; Juan José Fernández-Muñóz; María Laura Parra-Fernández Journal: Int J Environ Res Public Health Date: 2019-12-19 Impact factor: 3.390